Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

The economic burden of endoscopic treatment for anastomotic leaks following oncological Ivor Lewis esophagectomy.

Baltin C, Kron F, Urbanski A, Zander T, Kron A, Berlth F, Kleinert R, Hallek M, Hoelscher AH, Chon SH.

PLoS One. 2019 Aug 28;14(8):e0221406. doi: 10.1371/journal.pone.0221406. eCollection 2019.

2.

[The national Network Genomic Medicine (nNGM) : Model for innovative diagnostics and therapy of lung cancer within a public healthcare system].

Büttner R, Wolf J, Kron A; Nationales Netzwerk Genomische Medizin.

Pathologe. 2019 May;40(3):276-280. doi: 10.1007/s00292-019-0605-4. Review. German.

PMID:
31101971
3.

Safety and Efficacy of Crizotinib in Patients With Advanced or Metastatic ROS1-Rearranged Lung Cancer (EUCROSS): A European Phase II Clinical Trial.

Michels S, Massutí B, Schildhaus HU, Franklin J, Sebastian M, Felip E, Grohé C, Rodriguez-Abreu D, Abdulla DSY, Bischoff H, Brandts C, Carcereny E, Corral J, Dingemans AC, Pereira E, Fassunke J, Fischer RN, Gardizi M, Heukamp L, Insa A, Kron A, Menon R, Persigehl T, Reck M, Riedel R, Rothschild SI, Scheel AH, Scheffler M, Schmalz P, Smit EF, Limburg M, Provencio M, Karachaliou N, Merkelbach-Bruse S, Hellmich M, Nogova L, Büttner R, Rosell R, Wolf J.

J Thorac Oncol. 2019 Jul;14(7):1266-1276. doi: 10.1016/j.jtho.2019.03.020. Epub 2019 Apr 9.

PMID:
30978502
4.

Advance of theragnosis biomarkers in lung cancer: from clinical to molecular pathology and biology.

Alidousty C, Baar T, Heydt C, Wagener-Ryczek S, Kron A, Wolf J, Buettner R, Schultheis AM.

J Thorac Dis. 2019 Jan;11(Suppl 1):S3-S8. doi: 10.21037/jtd.2018.12.03. Review.

5.

Semantic and affective representations of valence: Prediction of autonomic and facial responses from feelings-focused and knowledge-focused self-reports.

Hamzani O, Mazar T, Itkes O, Petranker R, Kron A.

Emotion. 2019 Feb 4. doi: 10.1037/emo0000567. [Epub ahead of print]

PMID:
30714777
6.

K-ras Mutation Subtypes in NSCLC and Associated Co-occuring Mutations in Other Oncogenic Pathways.

Scheffler M, Ihle MA, Hein R, Merkelbach-Bruse S, Scheel AH, Siemanowski J, Brägelmann J, Kron A, Abedpour N, Ueckeroth F, Schüller M, Koleczko S, Michels S, Fassunke J, Pasternack H, Heydt C, Serke M, Fischer R, Schulte W, Gerigk U, Nogova L, Ko YD, Abdulla DSY, Riedel R, Kambartel KO, Lorenz J, Sauerland I, Randerath W, Kaminsky B, Hagmeyer L, Grohé C, Eisert A, Frank R, Gogl L, Schaepers C, Holzem A, Hellmich M, Thomas RK, Peifer M, Sos ML, Büttner R, Wolf J.

J Thorac Oncol. 2019 Apr;14(4):606-616. doi: 10.1016/j.jtho.2018.12.013. Epub 2018 Dec 31.

7.

Semantic and affective manifestations of ambi (valence).

Itkes O, Eviatar Z, Kron A.

Cogn Emot. 2019 Nov;33(7):1356-1369. doi: 10.1080/02699931.2018.1564249. Epub 2019 Jan 3.

PMID:
30602318
8.

Comparison of the genomic background of MET-altered carcinomas of the lung: biological differences and analogies.

Castiglione R, Alidousty C, Holz B, Wagener S, Baar T, Heydt C, Binot E, Zupp S, Kron A, Wolf J, Merkelbach-Bruse S, Reinhardt HC, Buettner R, Schultheis AM.

Mod Pathol. 2019 May;32(5):627-638. doi: 10.1038/s41379-018-0182-8. Epub 2018 Nov 20.

9.

Overcoming EGFRG724S-mediated osimertinib resistance through unique binding characteristics of second-generation EGFR inhibitors.

Fassunke J, Müller F, Keul M, Michels S, Dammert MA, Schmitt A, Plenker D, Lategahn J, Heydt C, Brägelmann J, Tumbrink HL, Alber Y, Klein S, Heimsoeth A, Dahmen I, Fischer RN, Scheffler M, Ihle MA, Priesner V, Scheel AH, Wagener S, Kron A, Frank K, Garbert K, Persigehl T, Püsken M, Haneder S, Schaaf B, Rodermann E, Engel-Riedel W, Felip E, Smit EF, Merkelbach-Bruse S, Reinhardt HC, Kast SM, Wolf J, Rauh D, Büttner R, Sos ML.

Nat Commun. 2018 Nov 7;9(1):4655. doi: 10.1038/s41467-018-07078-0.

10.

Construct validity of the family impact of assistive technology scale for augmentative and alternative communication.

Kron AT, Kingsnorth S, Wright FV, Ryan SE.

Augment Altern Commun. 2018 Dec;34(4):335-347. doi: 10.1080/07434618.2018.1518993. Epub 2018 Oct 29.

PMID:
30369255
11.

Impact of TP53 mutation status on systemic treatment outcome in ALK-rearranged non-small-cell lung cancer.

Kron A, Alidousty C, Scheffler M, Merkelbach-Bruse S, Seidel D, Riedel R, Ihle MA, Michels S, Nogova L, Fassunke J, Heydt C, Kron F, Ueckeroth F, Serke M, Krüger S, Grohe C, Koschel D, Benedikter J, Kaminsky B, Schaaf B, Braess J, Sebastian M, Kambartel KO, Thomas R, Zander T, Schultheis AM, Büttner R, Wolf J.

Ann Oncol. 2018 Oct 1;29(10):2068-2075. doi: 10.1093/annonc/mdy333.

12.

The effect of relevance appraisal on the emotional response.

Olteanu L, Golani S, Eitam B, Kron A.

Emotion. 2019 Jun;19(4):715-725. doi: 10.1037/emo0000473. Epub 2018 Aug 20.

PMID:
30124318
13.

Genetic instability and recurrent MYC amplification in ALK-translocated NSCLC: a central role of TP53 mutations.

Alidousty C, Baar T, Martelotto LG, Heydt C, Wagener S, Fassunke J, Duerbaum N, Scheel AH, Frank S, Holz B, Binot E, Kron A, Merkelbach-Bruse S, Ihle MA, Wolf J, Buettner R, Schultheis AM.

J Pathol. 2018 Sep;246(1):67-76. doi: 10.1002/path.5110. Epub 2018 Jul 31.

14.

Plerixafor in non-Hodgkin's lymphoma patients: a German analysis of time, effort and costs.

Hübel K, Ostermann H, Glaß B, Noppeney R, Kron F, Kron A, Milkovich G, Mohty M.

Bone Marrow Transplant. 2019 Jan;54(1):123-129. doi: 10.1038/s41409-018-0228-z. Epub 2018 May 24.

15.

Clinical and Pathological Characteristics of KEAP1- and NFE2L2-Mutated Non-Small Cell Lung Carcinoma (NSCLC).

Frank R, Scheffler M, Merkelbach-Bruse S, Ihle MA, Kron A, Rauer M, Ueckeroth F, König K, Michels S, Fischer R, Eisert A, Fassunke J, Heydt C, Serke M, Ko YD, Gerigk U, Geist T, Kaminsky B, Heukamp LC, Clement-Ziza M, Büttner R, Wolf J.

Clin Cancer Res. 2018 Jul 1;24(13):3087-3096. doi: 10.1158/1078-0432.CCR-17-3416. Epub 2018 Apr 3.

16.

Plerixafor in poor mobilizers with non-Hodgkin's lymphoma: a multi-center time-motion analysis.

Mohty M, Azar N, Chabannon C, Le Gouill S, Karlin L, Farina L, Milkovich G, Ostermann H, Glaß B, Noppeney R, Kron F, Kron A, Hübel K.

Bone Marrow Transplant. 2018 Mar;53(3):246-254. doi: 10.1038/s41409-017-0033-0. Epub 2017 Dec 18.

PMID:
29255168
17.

Promoting Sustainable Practices via Art.

Zuegge KL, Warren ME, Muldowney BL, Kron ATB.

Anesthesiology. 2017 Jul;127(1):206-207. doi: 10.1097/ALN.0000000000001684. No abstract available.

PMID:
28632631
18.

Dissociating affective and semantic valence.

Itkes O, Kimchi R, Haj-Ali H, Shapiro A, Kron A.

J Exp Psychol Gen. 2017 Jul;146(7):924-942. doi: 10.1037/xge0000291. Epub 2017 Apr 17.

PMID:
28414508
19.

Lean muscle volume of the thigh has a stronger relationship with muscle power than muscle strength in women with knee osteoarthritis.

Davison MJ, Maly MR, Keir PJ, Hapuhennedige SM, Kron AT, Adachi JD, Beattie KA.

Clin Biomech (Bristol, Avon). 2017 Jan;41:92-97. doi: 10.1016/j.clinbiomech.2016.11.005. Epub 2016 Nov 25.

PMID:
28038376
20.

Sex disparities in systemic sclerosis-associated pulmonary arterial hypertension: a cohort study.

Pasarikovski CR, Granton JT, Roos AM, Sadeghi S, Kron AT, Thenganatt J, Moric J, Chau C, Johnson SR.

Arthritis Res Ther. 2016 Jan 27;18:30. doi: 10.1186/s13075-016-0933-1.

21.

Psoriatic Arthritis Mutilans: Clinical and Radiographic Criteria. A Systematic Review.

Haddad A, Johnson SR, Somaily M, Fazelzad R, Kron AT, Chau C, Chandran V.

J Rheumatol. 2015 Aug;42(8):1432-8. doi: 10.3899/jrheum.141545. Epub 2015 Jun 15. Review.

PMID:
26077409
22.

Are valence and arousal separable in emotional experience?

Kron A, Pilkiw M, Banaei J, Goldstein A, Anderson AK.

Emotion. 2015 Feb;15(1):35-44. doi: 10.1037/a0038474.

PMID:
25664950
23.

Effectiveness of phosphodiesterase-5 inhibitor therapy for portopulmonary hypertension.

Fisher JH, Johnson SR, Chau C, Kron AT, Granton JT.

Can Respir J. 2015 Jan-Feb;22(1):42-6. Epub 2014 Dec 18.

24.

Peter Lee, MD, FRCPC, FRACP, 1943-2014.

Johnson SR, Kron AT.

J Rheumatol. 2014 Dec;41(12):2490. doi: 10.3899/jrheum.141204. No abstract available.

PMID:
25452184
25.

Spending one's time: the hedonic principle in ad libitum viewing of pictures.

Kron A, Pilkiw M, Goldstein A, Lee DH, Gardhouse K, Anderson AK.

Emotion. 2014 Dec;14(6):1087-101. doi: 10.1037/a0037696. Epub 2014 Aug 25.

PMID:
25151516
26.

Genetic characteristics of the human hepatic stellate cell line LX-2.

Weiskirchen R, Weimer J, Meurer SK, Kron A, Seipel B, Vater I, Arnold N, Siebert R, Xu L, Friedman SL, Bergmann C.

PLoS One. 2013 Oct 8;8(10):e75692. doi: 10.1371/journal.pone.0075692. eCollection 2013.

27.

Survival after lung transplantation in systemic sclerosis. A systematic review.

Khan IY, Singer LG, de Perrot M, Granton JT, Keshavjee S, Chau C, Kron A, Johnson SR.

Respir Med. 2013 Dec;107(12):2081-7. doi: 10.1016/j.rmed.2013.09.015. Epub 2013 Sep 26. Review.

28.

How are you feeling? Revisiting the quantification of emotional qualia.

Kron A, Goldstein A, Lee DH, Gardhouse K, Anderson AK.

Psychol Sci. 2013 Aug;24(8):1503-11. doi: 10.1177/0956797613475456. Epub 2013 Jul 3.

PMID:
23824581
29.

Estimation of skin phototypes with optical parameters: an experimental study using newly developed fibre optic detection device.

Ries F, Kapoustina V, Kron A, Fink A, Rädle M.

Int J Cosmet Sci. 2013 Feb;35(1):50-6. doi: 10.1111/ics.12003. Epub 2012 Oct 8.

PMID:
22994981
30.

Determination of alcohol and extract concentration in beer samples using a combined method of near-infrared (NIR) spectroscopy and refractometry.

Castritius S, Kron A, Schäfer T, Rädle M, Harms D.

J Agric Food Chem. 2010 Dec 22;58(24):12634-41. doi: 10.1021/jf1030604. Epub 2010 Nov 22.

PMID:
21090679
31.

Feelings don't come easy: studies on the effortful nature of feelings.

Kron A, Schul Y, Cohen A, Hassin RR.

J Exp Psychol Gen. 2010 Aug;139(3):520-34. doi: 10.1037/a0020008.

PMID:
20677897
32.

What is it that color determinants determine? The relation between the rorschach inkblot method and cognitive object-recognition processes.

Kron A, Cohen A, Benziman H, Ben-Shakhar G.

J Pers Assess. 2009 Mar;91(2):137-42. doi: 10.1080/00223890802634233.

PMID:
19205934
33.

Hypergonadotropic hypogonadism in a patient with inv ins (2;4).

Tzschach A, Ramel C, Kron A, Seipel B, Wüster C, Cordes U, Liehr T, Hoeltzenbein M, Menzel C, Ropers HH, Ullmann R, Kalscheuer V, Decker J, Steinberger D.

Int J Androl. 2009 Jun;32(3):226-30. Epub 2007 Nov 27.

PMID:
18042180
34.

Evaluation of the lambda model for human postural control during ankle strategy.

Micheau P, Kron A, Bourassa P.

Biol Cybern. 2003 Sep;89(3):227-36. Epub 2003 Aug 6.

PMID:
14504941
35.

Ectopic osteogenesis using adenoviral bone morphogenetic protein (BMP)-4 and BMP-6 gene transfer.

Jane JA Jr, Dunford BA, Kron A, Pittman DD, Sasaki T, Li JZ, Li H, Alden TD, Dayoub H, Hankins GR, Kallmes DF, Helm GA.

Mol Ther. 2002 Oct;6(4):464-70.

36.

Does a focal neurologic deficit contraindicate operation in a patient with endocarditis?

Parrino PE, Kron IL, Ross SD, Shockey KS, Kron AM, Towler MA, Tribble CG.

Ann Thorac Surg. 1999 Jan;67(1):59-64.

PMID:
10086525
37.

Preservation with 8-bromo-cyclic GMP improves pulmonary function after prolonged ischemia.

King RC, Laubach VE, Kanithanon RC, Kron AM, Parrino PE, Shockey KS, Tribble CG, Kron IL.

Ann Thorac Surg. 1998 Nov;66(5):1732-8.

PMID:
9875780
38.
39.

[Vojta's seven postural reactions in the detection of neuromotor disorders in infants. Experience with 2382 subjects].

Costi GC, Radice C, Raggi A, Kron AM, Angrisano A, Busato E, Montrasio G, Perfetti C, Pissacroia C.

Pediatr Med Chir. 1983 Mar-Apr;5(1-2):59-65. Italian.

PMID:
6634444
40.

Curvature of the protein chain in irregular regions.

Kron AK.

Mol Biol. 1974 Sep;8(2):249-51. No abstract available.

PMID:
4431420
41.

[Duffuse X-ray diffraction by polypeptides and proteins in solutions. II. Scattering in the beta-structural portions of the chain].

Voronin LA, Sarkisov GN, Kron AK, Fedorov BA.

Mol Biol. 1973 Jan-Feb;7(1):131-9. Russian. No abstract available.

PMID:
4721018

Supplemental Content

Support Center